Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deals
Biotech
Ono inks $700M biobuck deal to bag preclinical LigaChem ADC
LigaChem’s ADC is designed to deliver a therapeutic payload to cells that express L1CAM.
Nick Paul Taylor
Oct 10, 2024 9:40am
AI-powered Insitro taps Lilly to clear path to clinic for siRNA
Oct 9, 2024 9:28am
Boehringer inks $607M Circle pact for preclinical cancer program
Oct 9, 2024 8:36am
With Kezar in lupus limbo, Concentra spies potential acquisition
Oct 9, 2024 7:10am
Merck signs $1.9B deal to explore fibroblast therapies
Oct 8, 2024 8:55am
Galecto buys leukemia drug, drops bone cancer asset in pivot
Oct 7, 2024 10:07am
